Inflammatory and Autoimmune Diseases of the Nervous System; Possibilities of Laboratory Diagnostic Methods in Cerebrospinal Fluid

Folia Microbiologica

Volumn 48, Issue 6, 2003, Pages 839-847

  Lodin, Z ^a,b  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b NONE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1442266696     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02931522     Document Type: Review

References (64)

1. ADAM P.: Cytology of Cerebrospinal Fluid. Stapro, Pardubice (Czechia) 1995.
2. ADAM P.: Cytology of cerebrospinal fluid, pp. 78-91 in J. Tichý et al.: Neurology. Karolinum, Prague 1999.
3. ADAM P.: Protein fractions of cerebrospinal fluid, pp. 76-77 in J. Tichý et al.: Neurology. Karolinum, Prague 1999.
4. ADAM P.: Inflammatory diseases of nervous system, pp. 228-260 in J. Tichý et al.: Neurology. Karolinum, Prague 1999c.
5. ADAM P., NEKOLA P., HAVRDOVÁ E., PREININGEROVÁ J., TYL D., CHENÍČKOVÁ M., TAUBEROVÁ A., ZEMAN D., SOBEK O.: Evaluation of concentrations of apolipoprotein A-I in cerebrospinal fluid, correlations with the presence of lipophages in cytological findings. Klin.Biochem.Metab. 5, 8-12 (1997a).
6. ADAM P., NEKOLA P., HAVRDOVÁ E., PREININGEROVÁ J., TYL D., CHENÍČKOVÁ M., TAUBEROVÁ A., ZEMAN D., SOBEK O.: Evaluation of the role of C3 complement in cerebrospinal fluid. Klin.Biochem.Metab. 5, 33-36 (1997c).
7. ADAM P., NEKOLA P., HAVRDOVÁ E., PREININGEROVÁ J., TYL D., CHENÍČKOVÁ M., TAUBEROVÁ A., ZEMAN D., SOBEK O.: Evaluation of concentrations of orosomucoid in cerebrospinal fluid - a comparison with cytological CSF findings. Klin.Biochem.Metab. 5, 47-50 (1997c).
8. ADAM P., NEKOLA P., ZEMAN D, SOBEK O., KELBICH P., ARNOŠ TOVÁ L., CHENÍČKOVÁ M., TAUBEROVÁ A., KALISTOVÁ H., TYL D.: Routine diagnostic possibilities of cerebrospinal fluid cytology: proposal of classification of cytological findings, clinical advances and limits of used methods. Klin.Biochem.Metab. 6, 258-265 (1998a).
9. ADAM P., NEKOLA P., ZEMAN D., SOBEK O., KELBICH P., ARNOŠ TOVÁ L., CHENÍČKOVÁ M., TAUBEROVÁ A., KALISTOVÁ H., TYL D.: Methodology of quantitative assessment of concentration of specific and other proteins in cerebrospinal fluid. Klin.Biochem. Metab. 6, 265-267 (1998b).
10. ADAM P., NEKOLA P., ZEMAN D., SOBEK O., KELBICH P., ARNOŠ TOVÁ L., TYL D., CHENÍČKOVÁ M., TAUBEROVâ A., KALISTOVÂ H.: Biological role of apolipoprotein A-II in cerebrospinal fluid. Klin.Biochem.Metab. 6, 249-253 (1998c).
11. ADAM P., PETEROVÁ V., DOSTÁL C., SEIDL Z., OBENBERGER J., OLEJÁROVÁ M., TAUBEROVÁ A., TYL D., ZEMAN D., SOBEK O., KELBICH P.: CSF findings in systemic lupus erythematosus with impairment of CNS. Klin.Biochem.Metab. 6, 35-39 (1998d).
12. ADAM P., KRATOCHVÍLA J., BUDINA M.: Experiences with control cycle SEKK - liquorology. Fons 3, 29 (1999).
13. ADAM P., SOBEK O, ZITTA R., TÁBORSKÝ L., HILDEBRAND T., PRŮCHA M.: Quantitative evaluation of cerebrospinal fluid proteinogram using nephelometer BN II Dade-Behring. Klin.Biochem.Metab. 8, 213-216 (2000a).
14. ADAM P., TÁBORSKÝ L., PRŮCHA M., SOBEK O., KRATOCHVÍLA J., ZEMAN D.: Cerebrospinal Fluid Cytology. Medica News Publishers, Prague 2000a.
15. ADAM P., TÁBORSKÝ L., SOBEK O., HILDEBRAND T., KELBICH P., PRŮCHA M., HYÁNEK J.: Cerebrospinal fluid. Adv.Clin.Chem. 36, 1-62 (2001).
16. ADAM P., SOBEK O., TÁBORSKÝ L., PRŮCHA M., ŽÁČEK P.: Cerebrospinal fluid cytology. Riv.Med.Lab. 3, 46-51 (2002a).
17. ADAM P., TÁBORSKÝ L., SOBEK O., KELBICH P., PRŮCHA M., CIBIEN Č.: Proteinology of Cerebrospinal Fluid. Medica News Publishers, Prague 2002b.
18. ADAM P., VOTRUBA M., HRBKOVÁ M., SOBEK O., TUREK S.: The scavenger effect of albumin in CSF of patients with damaged blood brain barrier (The big albumin story - part 2). Klin.Biochem.Metab. 10, 122-125 (2002c).
19. ADAM P., SOBEK O., TÁBORSKÝ L., HILDEBRAND T., PRŮCHA M., HYÁNEK J., ŽÁČEK P., VESELÁ B.: Complete proteinogram of cerebrospinal fluid and its contribution to the diagnostics of inflammatory and autoimmune diseases of the central nervous system. 1st Fac.Med.Charles Univ.Quart.J. 104, 1-12 (2003).
20. ARATA L., LEONARDI A.: Oligoclonal and polyclonal synthesis of IgG in the central nervous system. An isoelectric focusing study. Clin.Immunol. Immunopathol. 47, 10-18 (1988).
21. ARNOŠTOVÁ L., ADAM P., NEKOLA P., ZEMAN D., SOBEK O., KELBICH P., TYL D., CHENÍČKOVÁ M., KALISTOVÁ H., TAUBEROVÁ A.: Evaluation of biological role of antithrombin III in cerebrospinal fluid. Klin.Biochem.Metab. 6, 241-245 (1998).
22. BOJAR M., MELUZÍNOVÁ E., ADAM P., GLOSSOVÁ E., LOCHMAN O.: Findings in cerebrospinal fluid in patients with neuroborreliosis treated by ceftizoxime. Klin.Biochem.Metab. 5, 14-19 (1997).
23. CHENÍČKOVÁ M., ADAM P., NEKOLA P.: Evaluation of CRP in cerebrospinal fluid in purulent meningitis. Klin.Biochem.Metab. 5, 27-30 (1997).
24. CHRISTIANSEN M., HOGDALL C.K., SELLEBJERG F., JALIASHVIL I., RASMUSSEN L.: Tetranectin in cerebrospinal fluid: evidence of intrathecal synthesis and potential as marker of neurological disease. Abstr. p. 524. Europ. CSF Symposium, Marburg (Germany) 1995; J.Lab.Med. 20, 9 (1996).
25. CHRISTIANSEN M., HOGDALL C.K., SELLEBJERG F., JALIASHVIL I., RASMUSSEN L.: Tetranectin in cerebrospinal fluid: evidence of intrathecal synthesis and potential as marker of neurological disease. Abstr. p. 524. Europ. CSF Symposium, Marburg (Germany) 1995; J.Lab.Med. 20, 9 (1996).
26. DUNIEWICZ M., ADAM P.: Neuro-infective Diseases. Maxdorf-Jesenius, Prague 1999.
27. FELGENHAUER K.: Laboratory diagnosis of neurological diseases, p. 1310 in L. Thomas (Ed.): Clinical Laboratory Diagnostics. Use and Assessment of Clinical Laboratory Results, 1st Engl. ed. TH-Books Verlagsgesellschaft, Frankfurt/Main (Germany) 1998.
28. GAHMBERG C.G., ANDERSSON L.C.: Leukocyte surface origin of human α-1-acid glycoprotein (orosomucoid). J.Exp.Med. 148, 507-521 (1978).
29. HANZAL F., SKALIČKOVÁ O., VIKLICKÝ J.: Cerebrospinal Fluid. State Medical Editorials, Prague 1963.
30. KALISTOVÁ H., ADAM P., NEKOLA P., SOBEK O., ZEMAN D., KELBICH P., ARNOŠTOVÁ L., TAUBEROVÁ A., TYL D.: Evaluation of biological role of haptoglobin in cerebrospinal fluid. Klin.Biochem.Metab. 6, 245-249 (1998).
31. KELBICH P., JÍLEK D., KRÁL V., DUCHKOVÁ H., FILIPOVSKÁ O., FAJKOŠOVÁ K., JÍLKOVÁ E., VACHOVÁ M., KOVÁŘOVÁ J., ADAM P., ZEMAN D., SOBEK O.: Cerebrospinal fluid findings in patients with neurosyphilis. Klin.Biochem.Metab. 8, 229-239 (2000).
32. KELBICH P., SLAVÍK S., JASANSKÁ J., ADAM P., HANULJAKOVÁ E., JERMANOVÁ K., ŘEPKOVÁ E., ŠIMEČKOVÁ M., PROCHÁZKOVÁ J., GAJDOŠOVÁ K., SOBEK O., ZEMAN D., NEKOLA P.: Evaluation of energetical situation in CSF compartment using assessment of selected parameters of glucose metabolism in CSF. Klin.Biochem.Metab. 6, 213-225 (1998).
33. KELBICH P., ŠIMEČKOVÁ M., ADAM P., VÁLKOVÁ R., HANULJAKOVÁ E., SOBEK O., TÁ BORSKÝ L., CHMELÍKOVÁ V., ZEMAN D., ŽÁ ČKOVÁ A.: Cerebrospinal fluid findings in patient with bacterial meningitis. Klin.Biochem.Metab. 10, 54-68 (2002).
34. KRZALIC L.: Prealbumin content of cerebrospinal fluid and sera in persons with multiple sclerosis. Clin.Chim.Acta 124, 339-341 (1982).
35. LAMOUREUX G., JOLICOEUR R., GIARD N., ST-HILAIRE M., DUPLANTIS F.: Cerebrospinal fluid proteins in multiple sclerosis. Neurology 25, 537-546 (1975).
36. LARSEN P.D., DELALLO L.J.: Cerebrospinal fluid transthyretin in multiple sclerosis. Neurology 37, 1262-1263 (1987).
37. MASOPUST J.: Clinical Biochemistry. Karolinum, Prague 1998.
38. MELUZÍNOVÁ E., ADAM P., BOJAR M.: Findings in cerebrospinal fluid in patients with neuroborreliosis. Klin.Biochem.Metab. 5, 12-14 (1997).
39. PREININGEROVÁ J., ADAM P., NEKOLA P., TYL D., TAUBEROVÁ A.: Levels of α-1-antitrypsin in cerebrospinal fluid in hematological malignancies impairing CNS. Klin.Biochem.Metab. 5, 30-32 (1997a).
40. PREININGEROVÁ J., ADAM P., NEKOLA P., TYL D.: Cytological findings in cerebrospinal fluid in tumors of CNS. Klin.Biochem.Metab. 5, 44-46 (1997b).
41. REIBER H.: The hyperbolic function: a mathematical solution of the protein flux/CSF flow model for blood CSF barrier function. J.Neurol.Sci. 126, 243-245 (1994).
42. REIBER H.: Diagnostic implication of neuroimmunological reaction patterns in cerebrospinal fluid. Lab.Med. 19, 444-462 (1995).
43. REIBER H., THOMPSON E.J., GRIMSLEY G., BERNARDI G., ADAM P., MONTEIRO DE ALMEIDA S., FREDMAN P., KEIR G., LAMMERS L., LIBLAU R., MENNA-BARRETO M., SÁ M.J., SERES E., SINDIC C.J.M., TEELKEN A., TRENDELENBURG C., TROJANO M., VAN ANTWERPEN M., VERBEEK M.M.: Quality assurance for cerebrospinal fluid analysis: international consensus by an internet-based group discussion. Clin.Chem.Lab.Med. 41, 331-337 (2003).
44. SCHMIDT R.M.: Der Liquor Cerebrospinalis. Georg-Thieme-Verlag, Leipzig (Germany) 1987.
45. SOBEK O., ADAM P., TÁBORSKÝ L., PRŮCHA M., VESELÁ B.: Acute and chronical forms of neuroborreliosis - cerebrospinal fluid differential diagnostics. Klin.Biochem.Metab. 10, 43-50 (2002).
46. SOBEK O., ADAM P., TÁBORSKÝ L., ZEMAN D., KELBICH P., HILDEBRAND T.: Protein fractions and other cerebrospinal fluid parameters in patients with multiple sclerosis. Klin.Biochem.Metab. 8, 209-212 (2000).
47. SOBEK O., ADAM P., ZEMAN D., KELBICH P., TAUBEROVÁ A., TYL D.: Cerebrospinal fluid parameters in patients with neuroborreliosis. Klin.Biochem.Metab. 6, 229-234 (1998).
48. SOBEK O., ADAM P.: Letter to the editors: on S. Seyfert, V. Kunzmann, N. Schwertfeger, H.C. Koch, A. Faulstich: Determinants of lumbal CSF protein concentration. J.Neurol. 250, 371-372 (2003).
49. SPENCE A.M.: Immunoglobulins in cerebrospinal fluid in multiple sclerosis. Human Pathol. 14, 99-103 (1983).
50. ŠTĚDRA J., LODIN Z.: Effects of neuromodulators on spleen and thymocyte cell proliferation and interleukin I (IL-1 production in the glioma C6 line. Histochem.J. 23, 503-508 (1991).
51. ŠTOURAČ P.: Differential diagnostic relevance of the blood CSF barrier function and oligoclonal IgG synthesis in cerebrospinal fluid in multiple sclerosis. Clin.Biochem.Metab. 6, 210-212 (1998).
52. ŠTOURAČ P.: Oligoclonal IgG synthesis in autoimmune neurological paraneoplastic syndromes. Clin.Biochem.Metab. 8, 224-228 (2000).
53. TÁBORSKÝ L., ADAM P., PRŮCHA M., SOBEK O., KRATOCHVÍLA J., ZEMAN D: Cytology of cerebrospinal fluid (CSF) on CD ROM. J.Lab.Med. 24, 571 (2000).
54. TÁBORSKÝ L., ADAM P., SOBEK O., DOSTÁL M., PRŮCHA M.: Evaluation of apolipoproteins A-I, A-II and B as markers of tissue destruction in cerebrospinal fluid in patients with neuroborreliosis. Clin.Chem.Lab.Med. 39, 111 (2001).
55. TÁBORSKÝ L., ADAM P., SOBEK O., DOSTÁL M., DVOŘÁKOVÁ J., DUBSKÁ L.: Apolipoproteins A-I, A-II and B as markers of tissue destruction in cerebrospinal fluid in patients with neuroborreliosis. Clin.Chem.Lab.Med. 40, 301 (2002).
56. TYL D., ADAM P.: Picture of intermeningeal hemorrhage in cerebrospinal fluid. Klin.Biochem.Metab. 5, 24-27 (1997).
57. VOTRUBA M., ADAM P., HRBKOVÁ M., HROUDOVÁ J., SOBEK O.: Mechanism of action of free radicals on functional state of blood CSF barrier. Klin.Biochem.Metab. 8, 240-243 (2000).
58. VRETHEM M., ÖHMAN S., VON SCHENCK H., FORSBERG P., OLSSON J.-E.: Comparison of concentration of orosomucoid in serum and cerebrospinal fluid in different neurological diseases. Acta Neurol.Scand. 76, 328-331 (1987).
59. 2-macroglobulin, and thrombin in human basilar arteries: relevance to cerebral vasospasm. J. Cerebr.Blood Flow Metab. 7, 68-73 (1987).
60. ZEMAN D., ADAM P., PREININGEROVÁ J., TYL D., TAUBEROVÁ A., SOBEK O.: Cytological findings in cerebrospinal fluid in multiple sclerosis. Klin.Biochem.Metab. 5, 50-57 (1997).
61. ZEMAN D., ADAM P, KALISTOVÁ H., SOBEK O., TAUBEROVÁ A., KELBICH P.: Changes of cytological finding and some biochemical parameters in cerebrospinal fluid of patients with multiple sclerosis after intrathecal administration of corticosteroids and cytostatics. Klin.Biochem.Metab. 6, 234-241 (1998).
62. ZEMAN D., ADAM P., KALISTOVÁ H., SOBEK O., KELBICH P., ANDĚL J., ANDĚL M.: Transferrin in patients with multiple sclerosis: a comparison among various subgroups of multiple sclerosis patients. Acta Neurol.Scand. 101, 89-94 (2000).
63. ZEMAN D., ADAM P., KALISTOVÁ H., SOBEK O., ANDĚL J., ANDĚL M.: Cerebrospinal fluid cytological findings in multiple sclerosis: a comparison between patient subgroups. Acta Cytol. 45, 51-59 (2001).
64. ZETTL U., LEHMITZ R., MIX E.: Klinische Liquordiagnostik. de Gruyter, Berlin-New York 2003.